IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. <\/p>\n
Company: \tChembio Diagnostics, Inc. Company: \tCardiome Pharma Corp. Company: \tTriangle Capital IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: Chembio Diagnostics, Inc. Symbol: CEMI Price: Last trade $8.45 Trade Date: 7\/29 Shares: 1.2 million Underwriter(s) Craig-Hallum Capital Group Co Manager(s)[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[860,861,862],"class_list":["post-1374","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-cemi","tag-crme","tag-tcap"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1374","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=1374"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1374\/revisions"}],"predecessor-version":[{"id":1375,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/1374\/revisions\/1375"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=1374"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=1374"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=1374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nSymbol: \tCEMI
\nPrice: \t\tLast trade $8.45
\nTrade Date: \t7\/29
\nShares: \t1.2 million
\nUnderwriter(s) Craig-Hallum Capital Group
\nCo Manager(s) The Benchmark Company
\nRating=Subscription Needed<\/a><\/p>\n
\nSymbol: \tCRME
\nPrice: \t\tLast trade $5.30
\nDescription: \tRe-offer range $3.00-$3.50
\nTrade Date: \t7\/26
\nShares: \t5.7 million shares
\nUnderwriter(s) Leerink Partners
\nRating=Subscription Needed<\/a><\/p>\n
\nSymbol: \tTCAP
\nPrice: \t\tLast trade $20.52
\nDescription: \tRe-offer range not available at this time.
\nTrade Date: \t7\/26
\nShares: \t6.25 million
\nUnderwriter(s) Morgan Stanley, Keefe, Bruyette & Woods, BofA Merrill Lynch, Robert Baird & Co., BB&T Capital Markets, Janney Montgomery Scott
\nCo Manager(s) JMP Securities, Wunderlich Securities, Houlihan Lokey Capital
\nRating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"